Last reviewed · How we verify
The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography (ALTAIR)
the purpose of this study is to show that alirocumab with statin therapy have a s tronger stabilizing effect on vulnerable plaque in coronary artery disease than statin alone administration
Details
| Lead sponsor | Kobe University |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 24 |
| Start date | Wed Aug 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Sep 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Coronary Artery Disease
- Thin-cap fIbroatheroma
Interventions
- Alirocumab
Countries
Japan